NCT00415116View on ClinicalTrials.gov

Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

carboplatin

DRUG

docetaxel

DRUG

lenalidomide

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

The Cleveland Clinic

OTHER

NCT00415116 - Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter